Dr. Ethel Feleder, Director of FP Clinical Pharma, has been selected by ANMAT to join the Network of Experts in Pharmacological Clinical Research.
Her new role as a member of the Advisory Committee involves providing specialized scientific advice to the National Health Authority.
A recognition that reaffirms her track record, commitment and excellence in the field of clinical research.
Congratulations, Dr. Feleder, on this honorable appointment! A source of pride for the entire F.P. Clinical Pharma team.
View official list of experts (ANMAT)On 01/20/2026, ANMAT Salud published Disposition 47/2026 in the Official Gazette, updating the list of APIs that must undergo bioequivalence/bioavailability studies.
Read moreBioequivalence affects not only treatment quality, but also everyday clinical decisions.
Read more